ArticleJournal of clinical microbiology2008
Acinetobacter baylyi as a pathogen for opportunistic infection.
Article in Journal of clinical microbiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 57 citations in OpenAlex.
- Effect of chemotherapeutic agents on natural transformation frequency in Acinetobacter baylyi.Access microbiology · 2024Article
- Engineered bacteria detect tumor DNA.Science (New York, N.Y.) · 2023Article
- Collection of Annotated Acinetobacter Genome Sequences.Microbiology resource announcements · 2023Article
- Lactobacillus spp. in the reproductive system of female moths and mating induced changes and possible transmission.BMC microbiology · 2022Article
- Antidepressants promote the spread of extracellular antibiotic resistance genes via transformation.ISME communications · 2022Article
- Engineered Cell Line Imaging Assay Differentiates Pathogenic from Non-Pathogenic Bacteria.Pathogens (Basel, Switzerland) · 2022Article
- Mating Leads to a Decline in the Diversity of Symbiotic Microbiomes and Promiscuity Increased Pathogen Abundance in a Moth.Frontiers in microbiology · 2022Article
- Non-antibiotic pharmaceuticals enhance the transmission of exogenous antibiotic resistance genes through bacterial transformation.The ISME journal · 2020Article
- Virus-induced genetics revealed by multidimensional precision medicine transcriptional workflow applicable to COVID-19.Physiological genomics · 2020Article
- One-Day Construction of Multiplex Arrays to Harness Natural CRISPR-Cas Systems.ACS synthetic biology · 2020Article
- Contact-Dependent Growth Inhibition Proteins in Acinetobacter baylyi ADP1.Current microbiology · 2018Article
- Article
- A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of Acinetobacter ursingii.BMC infectious diseases · 2015Article
- Fighting microbial drug resistance: a primer on the role of evolutionary biology in public health.Evolutionary applications · 2015Article
- Copy Number Change of the NDM-1 sequence in a multidrug-resistant Klebsiella pneumoniae clinical isolate.PloS one · 2013Article
- Bacterial recombination promotes the evolution of multi-drug-resistance in functionally diverse populations.Proceedings. Biological sciences · 2012Article
- Comparison of the virulence potential of Acinetobacter strains from clinical and environmental sources.PloS one · 2012Article
- Clinical carbapenem-resistant Acinetobacter baylyi strain coharboring blaSIM-1 and blaOXA-23 from China.Antimicrobial agents and chemotherapy · 2011Article
- Essential biological processes of an emerging pathogen: DNA replication, transcription, and cell division in Acinetobacter spp.Microbiology and molecular biology reviews : MMBR · 2010Review
- Exploring the evolutionary dynamics of plasmids: the Acinetobacter pan-plasmidome.BMC evolutionary biology · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There are no previous reports of human infection due to Acinetobacter baylyi. In this study, we report on six patients with bacteremia due to A. baylyi, based on analysis of the 16S-23S rRNA intergenic spacer and the 16S rRNA gene. All six patients had multiple underlying diseases. The infection was nosocomially acquired in five patients. The six clinical isolates had similar ribopatterns, suggesting a clonal relationship. Compared to the reference strain, the clinical isolates were more resistant to antimicrobial agents, especially beta-lactam antibiotics. In three of the isolates, they may have undetermined plasmid mediated class C type beta-lactamases because of the positive results in a double-disk synergy test using 3-aminophenylboronic acid. Two of the clinical isolates retained a level of natural transformability similar to that of the reference strain. None of the patients died, although only three of them received appropriate antimicrobial therapy. This study demonstrates that A. baylyi is a potential human pathogen that can cause nosocomial infection in immunocompromised patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.